APA ציטוט

Levy, A., Zou, D., Risebrough, N., Buckstein, R., Kim, T., & Brereton, N. (2014). Cost-effectiveness in Canada of azacitidine for the treatment of higher-risk myelodysplastic syndromes. Multimed Inc.

Citação norma Chicago

Levy, A.R., D. Zou, N. Risebrough, R. Buckstein, T. Kim, and N. Brereton. Cost-effectiveness in Canada of Azacitidine for the Treatment of Higher-risk Myelodysplastic Syndromes. Multimed Inc, 2014.

ציטוט MLA

Levy, A.R., et al. Cost-effectiveness in Canada of Azacitidine for the Treatment of Higher-risk Myelodysplastic Syndromes. Multimed Inc, 2014.